Src kinases in G-CSF receptor signaling

Frontiers in Bioscience

Volumn 12, Issue 4, 2007, Pages 1463-1474

  Sampson, Matthew ^a   Zhu, Quan Sheng ^b   Corey, Seth J ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

G CSF; Granuclocyte colony stimulating factor; Jak2; PI 3' kinase; Receptor; Review; Src

Indexed keywords

EID: 34249780512     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2160     Document Type: Article

References (124)

1. Shizuru, J. A., R. S. Negrin & I. L. Weissman: Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med, 56, 509-38 (2005)
2. Corey, S. J. & S. M. Anderson: Src-related protein tyrosine kinases in hematopoiesis. Blood, 93, 1-14 (1999)
3. Hermans, M. H., A. C. Ward, C. Antonissen, A. Karis, B. Lowenberg & I. P. Touw: Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colonystimulating factor receptor gene associated with severe chronic neutropenia. Blood, 92, 32-9 (1998)
4. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan & A. R. Dunn: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood, 84, 1737-46 (1994)
5. Liu, F., J. Poursine-Laurent & D. C. Link: The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood, 90, 2522-8 (1997)
6. Liu, F., H. Y. Wu, R. Wesselschmidt, T. Kornaga & D. C. Link: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity, 5, 491-501 (1996)
7. Fukunaga, R., E. Ishizaka-Ikeda, Y. Seto & S. Nagata: Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell, 61, 341-50 (1990)
8. Ihle, J. N., B. Witthuhn, B. Tang, T. Yi & F. W. Quelle: Cytokine receptors and signal transduction. Baillieres Clin Haematol, 7, 17-48 (1994)
9. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga & T. Kishimoto: Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA, 88, 11349-53 (1991)
10. Layton, J. E., G. Shimamoto, T. Osslund, A. Hammacher, D. K. Smith, H. R. Treutlein & T. Boone: Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor. Evidence that Glu19 of G-CSF interacts with Arg288 of the receptor. J Biol Chem, 274, 17445-51 (1999)
11. Layton, J. E., N. E. Hall, F. Cornell, J. Venhorst & H. R. Treutlein: Identification of ligand-binding site III on the immunoglobulin-like domain of the granulocyte colonystimulating factor receptor. J Biol Chem, 276, 36779-87 (2001)
12. Avalos, B. R., M. G. Hunter, J. M. Parker, S. K. Ceselski, B. J. Druker, S. J. Corey & V. B. Mehta: Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75c-rel. Blood, 85, 3117-26 (1995)
13. Barge, R. M., J. P. de Koning, K. Pouwels, F. Dong, B. Lowenberg & I. P. Touw: Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for GCSF-mediated activation of signaling complexes of the p21ras route. Blood, 87, 2148-53 (1996)
14. Nicholson, S. E., A. C. Oates, A. G. Harpur, A. Ziemiecki, A. F. Wilks & J. E. Layton: Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci USA, 91, 2985-8 (1994)
15. Akbarzadeh, S., A. C. Ward, D. O. McPhee, W. S. Alexander, G. J. Lieschke & J. E. Layton: Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells. Blood, 99, 879-87 (2002)
16. Corey, S. J., P. M. Dombrosky-Ferlan, S. Zuo, E. Krohn, A. D. Donnenberg, P. Zorich, G. Romero, M. Takata & T. Kurosaki: Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colonystimulating factor. JBiol Chem, 273, 3230-5 (1998)
17. de Koning, J. P., F. Dong, L. Smith, A. M. Schelen, R. M. Barge, D. C. van der Plas, L. H. Hoefsloot, B. Lowenberg & I. P. Touw: The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood, 87, 1335-42 (1996)
18. de Koning, J. P., A. M. Schelen, F. Dong, C. van Buitenen, B. M. Burgering, J. L. Bos, B. Lowenberg & I. P. Touw: Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood, 87, 132-40 (1996)
19. Chakraborty, A., K. F. Dyer, M. Cascio, T. A. Mietzner & D. J. Tweardy: Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood, 93, 15-24 (1999)
20. Zhuang, D., Y. Qiu, S. J. Haque & F. Dong: Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1. J Leukoc Biol (2005)
21. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, W. E. Thierfelder, B. Kreider & O. Silvennoinen: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci, 19, 222-7 (1994)
22. Parganas, E., D. Wang, D. Stravopodis, D. J. Topham, J. C. Marine, S. Teglund, E. F. Vanin, S. Bodner, O. R. Colamonici, J. M. van Deursen, G. Grosveld & J. N. Ihle: Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93, 385-95 (1998)
23. Rodig, S. J., M. A. Meraz, J. M. White, P. A. Lampe, J. K. Riley, C. D. Arthur, K. L. King, K. C. Sheehan, L. Yin, D. Pennica, E. M. Johnson, Jr. & R. D. Schreiber: Disruption of the Jakl gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell, 93, 373-83 (1998)
24. Neubauer, H., A. Cumano, M. Muller, H. Wu, U. Huffstadt & K. Pfeffer: Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell, 93, 397-409 (1998)
25. Martin, G. S.: The hunting of the Src. Nat Rev Mol Cell Biol, 2, 467-75 (2001)
26. Collett, M. S., A. F. Purchio & R. L. Erikson: Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine. Nature, 285, 167-9 (1980)
27. Hunter, T. & B. M. Sefton: Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U SA, 77, 1311-5 (1980)
28. Thomas, S. M. & J. S. Brugge: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol, 13, 513-609 (1997)
29. Moarefi, I., M. LaFevre-Bernt, F. Sicheri, M. Huse, C. H. Lee, J. Kuriyan & W. T. Miller: Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature, 385, 650-3 (1997)
30. Sicheri, F., I. Moarefi & J. Kuriyan: Crystal structure of the Src family tyrosine kinase Hck. Nature, 385, 602-9 (1997)
31. Roskoski, R., Jr.: Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun, 331, 1-14 (2005)
32. Hurley, T. R., R. Hyman & B. M. Sefton: Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the Ick, fyn, and c-src tyrosine protein kinases. Mol Cell Biol, 13, 1651-6 (1993)
33. Cahir McFarland, E. D., T. R. Hurley, J. T. Pingel, B. M. Sefton, A. Shaw & M. L. Thomas: Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA, 90, 1402-6 (1993)
34. Zhang, S. Q., W. Yang, M. I. Kontaridis, T. G. Bivona, G. Wen, T. Araki, J. Luo, J. A. Thompson, B. L. Schraven, M. R. Philips & B. G. Neel: Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell, 13, 341-55 (2004)
35. Cooper, J. A. & B. Howell: The when and how of Src regulation. Cell, 73, 1051-4 (1993)
36. Pierce, S. K.: Lipid rafts and B-cell activation. Nat Rev Immunol, 2, 96-105 (2002)
37. Kawabuchi, M., Y. Satomi, T. Takao, Y. Shimonishi, S. Nada, K. Nagai, A. Tarakhovsky & M. Okada: Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature, 404, 999-1003 (2000)
38. Vamosi, G., A. Bodnar, G. Vereb, A. Jenei, C. K. Goldman, J. Langowski, K. Toth, L. Matyus, J. Szollosi, T. A. Waldmann & S. Damjanovich: IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci USA, 101, 11082-7 (2004)
39. Bromann, P. A., H. Korkaya & S. A. Courtneidge: The interplay between Src family kinases and receptor tyrosine kinases. Oncogene, 23, 7957-68 (2004)
40. Arias-Salgado, E. G., S. Lizano, S. Sarkar, J. S. Brugge, M. H. Ginsberg & S. J. Shattil: Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci U S A, 100, 13298-302 (2003)
41. Ptasznik, A., E. Urbanowska, S. Chinta, M. A. Costa, B. A. Katz, M. A. Stanislaus, G. Demir, D. Linnekin, Z. K. Pan & A. M. Gewirtz: Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells. J Exp Med, 196, 667-78 (2002)
42. Chernock, R. D., R. P. Cherla & R. K. Ganju: SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood, 97, 608-15 (2001)
43. Holmes, T. C., D. A. Fadool, R. Ren & I. B. Levitan: Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain. Science, 274, 2089-91 (1996)
44. Kim, H., M. Laing & W. Muller: c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene, 24, 5629-36 (2005)
45. Irby, R. B. & T. J. Yeatman: Role of Src expression and activation in human cancer. Oncogene, 19, 5636-42 (2000)
46. Pawson, T. & J. D. Scott: Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075-80 (1997)
47. Songyang, Z. & L. C. Cantley: ZIP codes for delivering SH2 domains. Cell, 116, S41-3, 2 p following S48 (2004)
48. Huang, L. J., S. N. Constantinescu & H. F. Lodish: The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell, 8, 1327-38 (2001)
49. Resh, M. D.: Myristylation and palmitylation of Src family members: the fats of the matter. Cell, 76, 411-3 (1994)
50. Cunningham, B. C., M. Ultsch, A. M. De Vos, M. G. Mulkerrin, K. R. Clauser & J. A. Wells: Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science, 254, 821-5 (1991)
51. Remy, I., I. A. Wilson & S. W. Michnick: Erythropoietin receptor activation by a ligand-induced conformation change. Science, 283, 990-3 (1999)
52. Livnah, O., E. A. Stura, S. A. Middleton, D. L. Johnson, L. K. Jolliffe & I. A. Wilson: Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science, 283, 987-90 (1999)
53. Dahl, M. E., K. I. Arai & S. Watanabe: Association of Lyn tyrosine kinase to the GM-CSF and IL-3 receptor common betac subunit and role of Src tyrosine kinases in DNA synthesis and anti-apoptosis. Genes Cells, 5, 143-53 (2000)
54. Chin, H., A. Arai, H. Wakao, R. Kamiyama, N. Miyasaka & O. Miura: Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood, 91, 3734-45 (1998)
55. Tilbrook, P. A., E. Ingley, J. H. Williams, M. L. Hibbs & S. P. Klinken: Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. Embo J, 16, 1610-9 (1997)
56. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider & et al.: SH2 domains recognize specific phosphopeptide sequences. Cell, 72, 767-78 (1993)
57. Hatakeyama, M., T. Kono, N. Kobayashi, A. Kawahara, S. D. Levin, R. M. Perlmutter & T. Taniguchi: Interaction of the IL-2 receptor with the src-family kinase p561ck: identification of novel intermolecular association. Science, 252, 1523-8 (1991)
58. Arcasoy, M. O. & A. F. Karayal: Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain. Biochim Biophys Acta, 1740, 17-28 (2005)
59. Li, K., M. P. Menon, V. G. Karur, S. Hegde & D. M. Wojchowski: Attenuated signaling by a phosphotyrosinenull Epo receptor form in primary erythroid progenitor cells. Blood, 102, 3147-53 (2003)
60. Songyang, Z., K. L. Carraway, 3rd, M. J. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng & et al.: Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature, 373, 536-9 (1995)
61. Zhu, Q. S., L. J. Robinson, V. Roginskaya & S. J. Corey: G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood, 103, 3305-12 (2004)
62. Rausch, O. & C. J. Marshall: Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol, 17, 1170-9 (1997)
63. Hunter, M. G., A. Jacob, C. O'Donnell L, A. Agler, L. J. Druhan, K. M. Coggeshall & B. R. Avalos: Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J Immunol, 173, 5036-45 (2004)
64. van de Geijn, G. J., J. Gits, L. H. Aarts, C. HeijmansAntonissen & I. P. Touw: G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STATS but leave suppression of STAT3 intact. Blood, 104, 667-74 (2004)
65. Hermans, M. H., G. J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward & I. P. Touw: Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood, 101, 2584-90 (2003)
66. van de Geijn, G. J., J. Gits & I. P. Touw: Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol, 76, 237-44 (2004)
67. Dong, F., Y. Qiu, T. Yi, I. P. Touw & A. C. Larner: The carboxyl terminus of the granulocyte colonystimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol, 167, 6447-52 (2001)
68. Hock, H., M. J. Hamblen, H. M. Rooke, D. Traver, R. T. Bronson, S. Cameron & S. H. Orkin: Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity, 18, 109-20(2003)
69. Wang, Q. F. & A. D. Friedman: CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colonystimulating factor receptor. Blood, 99, 2776-85 (2002)
70. Yamanaka, R., C. Barlow, J. Lekstrom-Himes, L. H. Castilla, P. P. Liu, M. Eckhaus, T. Decker, A. Wynshaw-Boris & K. G. Xanthopoulos: Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A, 94, 13187-92 (1997)
71. Harder, K. W., L. M. Parsons, J. Armes, N. Evans, N. Kountouri, R. Clark, C. Quilici, D. Grail, G. S. Hodgson, A. R. Dünn & M. L. Hibbs: Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity, 15, 603-15 (2001)
72. Allen, R. C., P. R. Stevens, T. H. Price, G. S. Charta & D. C. Dale: In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J Infect Dis, 175, 1184-92(1997)
73. Hubel, K., D. C. Dale & W. C. Liles: Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colonystimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferongamma. J Infect Dis, 185, 1490-501 (2002)
74. Meng, F. & C. A. Lowell: Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med, 185, 1661-70 (1997)
75. Lowell, C. A., P. Soriano & H. E. Varmus: Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. Genes Dev, 8, 387-98 (1994)
76. Berton, G., A. Mocsai & C. A. Lowell: Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol, 26, 208-14 (2005)
77. Pereira, S. & C. Lowell: The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J Immunol, 171, 1319-27 (2003)
78. Grishin, A., S. Sinha, V. Roginskaya, M. J. Boyer, J. Gomez-Cambronero, S. Zuo, T. Kurosaki, G. Romero & S. J. Corey: Involvement of She and Cbl-PI 3-kinase in Lyndependent proliferative signaling pathways for G-CSF. Oncogene, 19, 97-105 (2000)
79. Aral, A., E. Kanda, Y. Nosaka, N. Miyasaka & O. Miura: CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling. J Biol Chem, 276, 33282-90 (2001)
80. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe & T. Yamamoto: Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity, 3, 549-60 (1995)
81. Hanazono, Y., H. Odai, K. Sasaki, A. Iwamatsu, Y. Yazaki & H. Hirai: Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells. Acta Haematol, 95, 236-42 (1996)
82. Kralovics, R., F. Passamonti, A. S. Buser, S. S. Teo, R. Tiedt, J. R. Passweg, A. Tichelli, M. Cazzola & R. C. Skoda: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med, 352, 1779-90 (2005)
83. Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wemig, B. J. Huntly, T. J. Boggon, I. Wlodarska, J. J. Clark, S. Moore, J. Adelsperger, S. Koo, J. C. Lee, S. Gabriel, T. Mercher, A. D'Andrea, S. Frohling, K. Dohner, P. Marynen, P. Vandenberghe, R. A. Mesa, A. Tefferi, J. D. Griffin, M. J. Eck, W. R. Sellers, M. Meyerson, T. R. Golub, S. J. Lee & D. G. Gilliland: Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387-97 (2005)
84. James, C., V. Ugo, J. P. Le Couedic, J. Staerk, F. Delhommeau, C. Lacout, L. Garcon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, J. L. Villeval, S. N. Constantinescu, N. Casadevall & W. Vainchenker: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144-8 (2005)
85. Baxter, E. J., L. M. Scott, P. J. Campbell, C. East, N. Fourouclas, S. Swanton, G. S. Vassiliou, A. J. Bench, E. M. Boyd, N. Curtin, M. A. Scott, W. N. Erber & A. R. Green: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054-61 (2005)
86. Corey, S. J., A. L. Burkhardt, J. B. Bolen, R. L. Geahlen, L. S. Tkatch & D. J. Tweardy: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci USA, 91, 4683-7 (1994)
87. Ward, A. C., J. L. Monkhouse, X. F. Csar, I. P. Touw & P. A. Bello: The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor. Biochem Biophys Res Commun, 251, 117-23 (1998)
88. Wang, L., W. A. Rudert, I. Loutaev, V. Roginskaya & S. J. Corey: Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene, 21, 5346-55 (2002)
89. Playford, M. P. & M. D. Schaller: The interplay between Src and integrins in normal and tumor biology. Oncogene, 23, 7928-46 (2004)
90. Frame, M. C.: Newest findings on the oldest oncogene; how activated src does it. J Cell Sci, 117, 989-98 (2004)
91. Takata, M., H. Sabe, A. Hata, T. Inazu, Y. Homma, T. Nukada, H. Yamamura & T. Kurosaki: Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. Embo J, 13, 1341-9 (1994)
92. Qin, S., T. Inazu, M. Takata, T. Kurosaki, Y. Homma & H. Yamamura: Cooperation of tyrosine kinases p72syk and p53/561yn regulates calcium mobilization in chicken B cell oxidant stress signaling. Eur J Biochem, 236, 443-9 (1996)
93. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs & D. M. Tarlinton: Lyn tyrosine kinase: accentuating the positive and the negative. Immunity, 22, 9-18 (2005)
94. Lannutti, B. J. & J. G. Drachman: Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors. Blood, 103, 3736-43 (2004)
95. Santini, V., B. Scappini, A. Grossi, A. Gozzini, L. Bonsi, G. Pagliai, P. Rossi Ferrini & G. P. Bagnara: Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647. Haematologica, 87, 1242-7 (2002)
96. Yu, C. L., R. Jove & S. J. Burakoff: Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J Immunol, 159, 5206-10 (1997)
97. Cobb, M. H., J. E. Hepler, M. Cheng & D. Robbins: The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol, 5, 261-8 (1994)
98. Bashey, A., L. Healy & C. J. Marshall: Proliferative but not nonproliferative responses to granulocyte colonystimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood, 83, 949-57 (1994)
99. Nicholson, S. E., U. Novak, S. F. Ziegler & J. E. Layton: Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood, 86, 3698-704 (1995)
100. Rausch, O. & C. J. Marshall: Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colonystimulating factor-induced hemopoietic cell proliferation. J Biol Chem, 274, 4096-105 (1999)
101. Baumann, M. A., C. C. Paul, S. Lemley-Gillespie, M. Oyster & J. Gomez-Cambronero: Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing. Am JHematol, 68, 99-105 (2001)
102. Dong, F., J. S. Gutkind & A. C. Lamer: Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. JBiol Chem, 276, 10811-6 (2001)
103. de Koning, J. P., A. A. Soede-Bobok, A. M. Schelen, L. Smith, D. van Leeuwen, V. Santini, B. M. Burgering, J. L. Bos, B. Lowenberg & I. P. Touw: Proliferation signaling and activation of She, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood, 91, 1924-33 (1998)
104. Garcia, J., J. de Gunzburg, A. Eychene, S. Gisselbrecht & F. Porteu: Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rapl-B-Raf-dependent pathways. Mol Cell Biol, 21, 2659-70 (2001)
105. Cantley, L. C.: The phosphoinositide 3-kinase pathway. Science, 296, 1655-7 (2002)
106. Dong, F. & A. C. Larner: Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood, 95, 1656-62 (2000)
107. Dong, F., M. van Paassen, C. van Buitenen, L. H. Hoefsloot, B. Lowenberg & I. P. Touw: A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood, 85, 902-11 (1995)
108. Fujita, E., A. Jinbo, H. Matuzaki, H. Konishi, U. Kikkawa & T. Momoi: Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun, 264, 550-5 (1999)
109. Mayo, L. D. & D. B. Donner: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci US A, 98, 11598-603 (2001)
110. Burgering, B. M. & R. H. Medema: Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol, 73, 689-701 (2003)
111. Luo, J., B. D. Manning & L. C. Cantley: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell, 4, 257-262 (2003)
112. Zhu, Q.-S., L. Xia, G. M. Mills, C. A. Lowell, I. P. Touw & S. J. Corey: G-CSF induced reactive oxygen species involves Lyn-PI 3-kinase-Akt and contributes to myeloid cell growth. Blood (2005)
113. Miyazato, A., Y. Yamashita, K. Hatake, Y. Miura, K. Ozawa & H. Mano: Tec protein tyrosine kinase is involved in the signaling mechanism of granulocyte colony-stimulating factor receptor. Cell Growth Differ, 7, 1135-9 (1996)
114. Mano, H., Y. Yamashita, A. Miyazato, Y. Miura & K. Ozawa: Tec protein-tyrosine kinase is an effector molecule of Lyn protein-tyrosine kinase. Faseb J, 10, 637-42 (1996)
115. Reddy, E. P., A. Korapati, P. Chaturvedi & S. Rane: IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene, 19, 2532-47 (2000)
116. Rane, S. G. & E. P. Reddy: JAKs, STATs and Src kinases in hematopoiesis. Oncogene, 21, 3334-58 (2002)
117. Sinha, S., K. Rothermund, S. Watkins, Q. S. Zhu, G. Romero & S. J. Corey: Deletional mutation of the external domain of the human Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Patient with Severe Chronic Neutropenia refractory to Granulocyte Colony-Stimulating Factor. J Ped Hematol Oncol (2003)
118. Druhan, L. J., J. Ai, P. Massullo, T. Kindwall-Keller, M. A. Ranalli & B. R. Avalos: Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. Blood, 105, 584-91 (2005)
119. Ward, A. C., Y. M. van Aesch, J. Gits, A. M. Schelen, J. P. de Koning, D. van Leeuwen, M. H. Freedman & I. P. Touw: Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med, 190, 497-507 (1999)
120. White, S. M., E. D. Ball, W. C. Ehmann, A. S. Rao & D. J. Tweardy: Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia, 12, 899-906 (1998)
121. Wolfler, A., S. J. Erkeland, C. Bodner, M. Valkhof, W. Renner, C. Leitner, W. Olipitz, M. Pfeilstocker, C. Tinchon, W. Emberger, W. Linkesch, I. P. Touw & H. Sill: A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome. Blood, 105, 3731-6 (2005)
122. Roginskaya, V., S. Zuo, E. Caudell, G. Nambudiri, A. J. Kraker & S. J. Corey: Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth. Leukemia, 13, 855-61 (1999)
123. Shah, N. P., C. Tran, F. Y. Lee, P. Chen, D. Norris & C. L. Sawyers: Overriding imatinib resistance with a novel ABL kinase inhibitor. Science, 305, 399-401 (2004)
124. Nishizumi, H., K. Horikawa, I. Mlinaric-Rascan & T. Yamamoto: A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J Exp Med, 187, 1343-8 (1998)